Central Admixture Pharmacy Services Inc

CLOSEOUT LETTER Central Admixture Pharmacy Services Inc MARCS-CMS 497021 — May 27, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Drugs Recipient: Recipient Name Thomas J. Wilverding Recipient Title President Central Admixture Pharmacy Services Inc 6800 Aston Street Suite 150 Irvine , CA 92606 United States Issuing Office: Division of Pharmaceutical Quality Operations IV United States (949) 608-2900 Dear Mr. Wilverding: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter # 40-16, issued August 18, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ CDR Steven E. Porter, Jr. Director, Division of Pharmaceutical Quality Operations IV Content current as of: 06/12/2020 Regulated Product(s) Drugs